Cargando…

Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study

OBJECTIVE: Canadian fetal alcohol spectrum disorder (FASD) guidelines encourage an age-specific interdisciplinary diagnostic approach. However, there is currently no standard-of-care regarding FASD diagnosis disclosure and few studies document Canadian FASD clinical capacity. Our objectives were to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dugas, Erika N., Poirier, Martine, Basque, Dominique, Bouhamdani, Nadia, LeBreton, Laure, Leblanc, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438035/
https://www.ncbi.nlm.nih.gov/pubmed/36041771
http://dx.doi.org/10.1136/bmjopen-2022-065005
_version_ 1784781738462937088
author Dugas, Erika N.
Poirier, Martine
Basque, Dominique
Bouhamdani, Nadia
LeBreton, Laure
Leblanc, Nicole
author_facet Dugas, Erika N.
Poirier, Martine
Basque, Dominique
Bouhamdani, Nadia
LeBreton, Laure
Leblanc, Nicole
author_sort Dugas, Erika N.
collection PubMed
description OBJECTIVE: Canadian fetal alcohol spectrum disorder (FASD) guidelines encourage an age-specific interdisciplinary diagnostic approach. However, there is currently no standard-of-care regarding FASD diagnosis disclosure and few studies document Canadian FASD clinical capacity. Our objectives were to describe clinical capacity (defined as skills and resources) for FASD assessment, diagnosis, disclosure and support in Canada. DESIGN, SETTING AND PARTICIPANTS: Data were drawn from the CanDiD study, a cross-sectional investigation of Canadian FASD clinical capacity. Forty-one clinics participated in the study. Data were collected in 2021 on the number and types of health professionals included in the assessment and diagnostic teams, the presence (or absence) of a minor patient when the FASD diagnosis is disclosed to parents/guardians, who is responsible for the diagnosis disclosure, the use of explanatory tools, and the types of support/counselling services available. The proportion of clinics that follow the Canadian interdisciplinary diagnostic guidelines by age group is described among participating clinics. RESULTS: Overall, 21, 13 and 7 specialised FASD clinics were in Western/Northern, Central and Atlantic Canada, respectively. The number of referrals per year surpassed the number of diagnostic assessments completed in all regions. Approximately, 60% of clinics who diagnosed FASD in infants and preschool children (n=4/7 and 15/25, respectively) followed the interdisciplinary guidelines compared with 80% (n=32/40) in clinics who diagnosed school-aged children/adolescents. Diagnostic reporting practices were heterogeneous, but most used an explanatory tool with children/adolescents (67%), offered support/counselling (90–95%) and used case-by-case approach (80%) when deciding who would disclose the diagnosis to the child/adolescent and when. CONCLUSIONS: Limited diagnostic capacity and lack of FASD resources across Canada highlights a critical need for continued FASD support. This study identifies gaps in assessment, diagnosis and reporting practices for FASD in children/adolescents across Canada.
format Online
Article
Text
id pubmed-9438035
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94380352022-09-14 Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study Dugas, Erika N. Poirier, Martine Basque, Dominique Bouhamdani, Nadia LeBreton, Laure Leblanc, Nicole BMJ Open Paediatrics OBJECTIVE: Canadian fetal alcohol spectrum disorder (FASD) guidelines encourage an age-specific interdisciplinary diagnostic approach. However, there is currently no standard-of-care regarding FASD diagnosis disclosure and few studies document Canadian FASD clinical capacity. Our objectives were to describe clinical capacity (defined as skills and resources) for FASD assessment, diagnosis, disclosure and support in Canada. DESIGN, SETTING AND PARTICIPANTS: Data were drawn from the CanDiD study, a cross-sectional investigation of Canadian FASD clinical capacity. Forty-one clinics participated in the study. Data were collected in 2021 on the number and types of health professionals included in the assessment and diagnostic teams, the presence (or absence) of a minor patient when the FASD diagnosis is disclosed to parents/guardians, who is responsible for the diagnosis disclosure, the use of explanatory tools, and the types of support/counselling services available. The proportion of clinics that follow the Canadian interdisciplinary diagnostic guidelines by age group is described among participating clinics. RESULTS: Overall, 21, 13 and 7 specialised FASD clinics were in Western/Northern, Central and Atlantic Canada, respectively. The number of referrals per year surpassed the number of diagnostic assessments completed in all regions. Approximately, 60% of clinics who diagnosed FASD in infants and preschool children (n=4/7 and 15/25, respectively) followed the interdisciplinary guidelines compared with 80% (n=32/40) in clinics who diagnosed school-aged children/adolescents. Diagnostic reporting practices were heterogeneous, but most used an explanatory tool with children/adolescents (67%), offered support/counselling (90–95%) and used case-by-case approach (80%) when deciding who would disclose the diagnosis to the child/adolescent and when. CONCLUSIONS: Limited diagnostic capacity and lack of FASD resources across Canada highlights a critical need for continued FASD support. This study identifies gaps in assessment, diagnosis and reporting practices for FASD in children/adolescents across Canada. BMJ Publishing Group 2022-08-30 /pmc/articles/PMC9438035/ /pubmed/36041771 http://dx.doi.org/10.1136/bmjopen-2022-065005 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Paediatrics
Dugas, Erika N.
Poirier, Martine
Basque, Dominique
Bouhamdani, Nadia
LeBreton, Laure
Leblanc, Nicole
Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study
title Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study
title_full Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study
title_fullStr Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study
title_full_unstemmed Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study
title_short Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study
title_sort canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study
topic Paediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438035/
https://www.ncbi.nlm.nih.gov/pubmed/36041771
http://dx.doi.org/10.1136/bmjopen-2022-065005
work_keys_str_mv AT dugaserikan canadianclinicalcapacityforfetalalcoholspectrumdisorderassessmentdiagnosisdisclosureandsupporttochildrenandadolescentsacrosssectionalstudy
AT poiriermartine canadianclinicalcapacityforfetalalcoholspectrumdisorderassessmentdiagnosisdisclosureandsupporttochildrenandadolescentsacrosssectionalstudy
AT basquedominique canadianclinicalcapacityforfetalalcoholspectrumdisorderassessmentdiagnosisdisclosureandsupporttochildrenandadolescentsacrosssectionalstudy
AT bouhamdaninadia canadianclinicalcapacityforfetalalcoholspectrumdisorderassessmentdiagnosisdisclosureandsupporttochildrenandadolescentsacrosssectionalstudy
AT lebretonlaure canadianclinicalcapacityforfetalalcoholspectrumdisorderassessmentdiagnosisdisclosureandsupporttochildrenandadolescentsacrosssectionalstudy
AT leblancnicole canadianclinicalcapacityforfetalalcoholspectrumdisorderassessmentdiagnosisdisclosureandsupporttochildrenandadolescentsacrosssectionalstudy